EW
36
-4
MPC
39
-15
OMC
55
-7
HES
71
-8
CMI
50
-6
EQR
62
-5
VMC
69
-3
AMGN
50
-4
APD
39
-6
CSX
39
-4
PM
43
-4
MRK
66
-3
KLAC
63
-5
PHM
69
-2
CB
44
-3
TEL
71
-6
UNP
48
-5
LUV
49
-3
PSA
43
6
PWR
72
-4
EW
36
-4
MPC
39
-15
OMC
55
-7
HES
71
-8
CMI
50
-6
EQR
62
-5
VMC
69
-3
AMGN
50
-4
APD
39
-6
CSX
39
-4
PM
43
-4
MRK
66
-3
KLAC
63
-5
PHM
69
-2
CB
44
-3
TEL
71
-6
UNP
48
-5
LUV
49
-3
PSA
43
6
PWR
72
-4
Financhill
Back

DexCom Quote, Financials, Valuation and Earnings

My #1 Coin is...

All the details are on the next page.
Buy
61

DXCM
DexCom

Last Price:
125.98
Seasonality Move:
11.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

DexCom Price Quote

$125.98
+0.10 (+-1.11%)
(Updated: May 2, 2024 at 3:32 AM ET)

DexCom Key Stats

Buy
61
DexCom (DXCM) is a Buy
Day range:
$123.52 - $128.74
52-week range:
$74.75 - $142.00
Dividend yield:
0%
P/E ratio:
97.99
P/S ratio:
14.17
P/B ratio:
22.55%
Volume:
2.6M
Avg. volume:
2.8M
1-year change:
6.28%
Market cap:
$50.7B
Revenue:
$3.6B
EPS:
$1.55

How Much Does DexCom Make?

  • How Much Are DexCom's Sales Annually?
    DXCM Revenues are $3.6B
  • How Much Profit Does DexCom's Make A Year?
    DXCM net income is $541.5M

Is DexCom Growing As A Company?

  • What Is DexCom's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.24%
  • What Is DexCom's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 2%

DexCom Stock Price Performance

  • Did DexCom Stock Go Up Last Month?
    DexCom share price went down by -8.74% last month
  • Did DXCM's Share Price Rise Over The Last Year?
    DXCM share price rose by 6.28% over the past 1 year

What Is DexCom 52-Week High & Low?

  • What Is DexCom’s 52-Week High Share Price?
    DexCom has traded as high as $142.00 over the past 52 weeks
  • What Is DexCom’s 52-Week Low Share Price?
    DexCom has traded as low as $74.75 over the past 52 weeks

DexCom Price To Free Cash Flow

  • Is DexCom Stock Overvalued?
    DexCom is trading at a price to free cash flow ratio of 92.36
  • Is DexCom Stock Undervalued?
    DexCom EV to Free Cash Flow ratio is 86.03
  • What Is DexCom’s Price Earnings Growth Ratio?
    DXCM PEG ratio is 0.68
  • Is DexCom Trading At A Premium To Earnings?
    DexCom EV to EBIT ratio is 62.85

Is It Risky To Buy DexCom?

  • How Much Debt Does DexCom Have?
    Total long term debt quarterly is $2.4B
  • How Much Cash Does DexCom Have?
    Cash and short term investments quarterly total is $2.9B
  • What Is DexCom’s Book Value Per Share?
    Book value per share is 5.67

Is DexCom Cash Flow Positive?

  • What Is DXCM Cash Flow From Operations?
    Cash flow from operations (TTM) is $802.3M
  • What Is DexCom’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$325.1M
  • What Is DexCom’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$245.7M

DexCom Return On Invested Capital

  • Is Management Doing A Good Job?
    DXCM return on invested capital is 13.59%
  • What Is DexCom Return On Assets?
    ROA measures how assets are converting to revenues and is 10.09%
  • What Is DXCM Return On Equity?
    ROE is a measure of profitability and is 29.28%

DexCom Earnings Date & Stock Price

  • What Is DexCom's Stock Price Today?
    A single share of DXCM can be purchased today for 125.88
  • What Is DexCom’s Stock Symbol?
    DexCom trades on the nasdaq under the ticker symbol: DXCM
  • When Is DexCom’s Next Earnings Date?
    The next quarterly earnings date for DexCom is scheduled on July 26, 2024
  • When Is DXCM's next ex-dividend date?
    DexCom's next ex-dividend date is May 1, 2020
  • How To Buy DexCom Stock?
    You can buy DexCom shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

DexCom Competitors

  • Who Are DexCom's Competitors?
    Below is a list of companies who compete with DexCom or are related in some way:
    • Abbott Laboratories (ABT)
    • Cardinal Health Inc (CAH)
    • Edwards Lifesciences Corp (EW)
    • Intuitive Surgical Inc (ISRG)
    • Insulet Corp (PODD)

DexCom Dividend Yield

Data Unavailable

DexCom Analyst Estimates

YoY Growth Past Surprise
EPS: 200% 18.61%
Revenue: 24.21% 1.11%

Analyst Recommendations

Buy Recommendations: 18
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 150.38
Upside from Last Price: 19.46%

Major Shareholders

  • How many DXCM shares are owned by institutional investors?
    613.2M DXCM shares are owned by institutional investors
  • How many DXCM shares are owned by insiders?
    2.7M DXCM shares are owned by insiders